Hostname: page-component-848d4c4894-p2v8j Total loading time: 0.001 Render date: 2024-05-19T13:31:02.523Z Has data issue: false hasContentIssue false

Comparison of Two Anti-Depressant Drugs (Imipramine and Pheniprazine) In Endogenous Depressive Illnesses in Female In-Patients

Published online by Cambridge University Press:  08 February 2018

Donald P. Oakley*
Affiliation:
Whittingham Hospital, Preston. (Now Assistant Psychiatrist, York Mental Health Service.)

Extract

The following study was designed to compare the effectiveness of imipramine (Tofranil) and pheniprazine (Cavodil) in the treatment of endogenous depression. Controlled trials have shown the value of imipramine (Holdway, 1960) and therefore no placebo group was included. The theoretical advantages of a cross-over technique were considered to be outweighed by such disadvantages as the tendency for the effects of the first therapeutic agent to continue into the second phase of the experiment; and the tendency for rapid remissions to occur with anti-depressive drugs and to persist for a period despite withdrawal. Thus two similar groups of patients, each treated with full dosage of their respective drugs, were compared. The selection of patients was randomized, and the trial was blind throughout.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Crisp, A. H., Hays, P., and Carter, A., Lancet, 1961, i, 17.Google Scholar
Holdway, V., J. Ment. Sci., 1960, 106, 1443.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.